Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Gaëlle Naert |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice / Gaëlle Naert en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.11 (Noviembre)
[artículo]
Título : Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice Tipo de documento: texto impreso Autores: Gaëlle Naert, Autor ; Valentine Ferré, Autor ; Johann Meunier, Autor Fecha de publicación: 2021 Artículo en la página: pp. 2170-2182 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Quinasa, DYRK1A, Leucettines, Aβ 25–35, Toxicidad amiloide, Fosforilación de tau Resumen: Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer’s disease (AD). DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathological proteins in AD. Link: ./index.php?lvl=notice_display&id=26703
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.11 (Noviembre) . - pp. 2170-2182[artículo] Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice [texto impreso] / Gaëlle Naert, Autor ; Valentine Ferré, Autor ; Johann Meunier, Autor . - 2021 . - pp. 2170-2182.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.11 (Noviembre) . - pp. 2170-2182
Palabras clave: Quinasa, DYRK1A, Leucettines, Aβ 25–35, Toxicidad amiloide, Fosforilación de tau Resumen: Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer’s disease (AD). DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathological proteins in AD. Link: ./index.php?lvl=notice_display&id=26703